Misecellaneous antimalarials are drugs effective in the treatment of malaria. Malaria is an infectious disease caused by the bite of an anopheles mosquito infected with certain protozoans. The best way to prevent malaria is by taking antimalarial drugs prophylactically prior to entering an endemic area.
This report contains market size and forecasts of Miscellaneous Antimalarials in Global, including the following market information:
Global Miscellaneous Antimalarials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Miscellaneous Antimalarials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Doxycyline Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Miscellaneous Antimalarials include Norvatis, Teva Pharmaceutical Industries, Bayer AG., GlaxoSmithKline Plc., Ipca Laboratories Ltd., Milan Pharmaceuticals, Paso Laboratories, Glenmark Pharmaceutical Inc. and Zydus Cadila. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Miscellaneous Antimalarials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Miscellaneous Antimalarials Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Miscellaneous Antimalarials Market Segment Percentages, by Type, 2021 (%)
Doxycyline
Pyrimethamine
Halofantrine
Global Miscellaneous Antimalarials Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Miscellaneous Antimalarials Market Segment Percentages, by Application, 2021 (%)
Prevention
Treatment
Global Miscellaneous Antimalarials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Miscellaneous Antimalarials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Miscellaneous Antimalarials revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Miscellaneous Antimalarials revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Norvatis
Teva Pharmaceutical Industries
Bayer AG.
GlaxoSmithKline Plc.
Ipca Laboratories Ltd.
Milan Pharmaceuticals
Paso Laboratories
Glenmark Pharmaceutical Inc.
Zydus Cadila